Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingo Just

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 4, 2011
Therapeutic effects of Clostridium botulinum C3 exoenzymeIngo Just, Astrid Rohrbeck, Stefanie C Huelsenbeck, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 4, 2014
Binding of Clostridium botulinum C3 exoenzyme to intact cellsAstrid Rohrbeck, Leonie von Elsner, Sandra Hagemann, et al.
Toxins|February 5, 2015
Uptake of clostridium botulinum C3 exoenzyme into intact HT22 and J774A.1 cellsAstrid Rohrbeck, Leonie von Elsner, Sandra Hagemann, et al.
Journal of Molecular Signaling|September 14, 2018
Anti-proliferative Effect of C3 Exoenzyme in Fibroblasts is Mediated by c-Jun PhosphorylationLeonie von Elsner, Sandra Hagemann, Ingo Just, et al.
The International Journal of Biochemistry & Cell Biology|February 22, 2008
Clostridium difficile toxins: more than mere inhibitors of Rho proteinsHarald Genth, Stefanie C Dreger, Johannes Huelsenbeck, et al.
Infection and Immunity|September 22, 2006
Application of mutated Clostridium difficile toxin A for determination of glucosyltransferase-dependent effectsMatthias Teichert, Helma Tatge, Janett Schoentaube, et al.
The FEBS Journal|May 25, 2012
Distinct biological activities of C3 and ADP-ribosyltransferase-deficient C3-E174QAstrid Rohrbeck, Tanja Kolbe, Sandra Hagemann, et al.
Biochemical and Biophysical Research Communications|February 21, 2003
Activation of phospholipase D1 by ADP-ribosylated RhoAHarald Genth, Martina Schmidt, Ralf Gerhard, et al.
Cellular Microbiology|August 28, 2009
Serine-71 phosphorylation of Rac1/Cdc42 diminishes the pathogenic effect of Clostridium difficile toxin AJanett Schoentaube, Alexandra Olling, Helma Tatge, et al.
Biochemical and Biophysical Research Communications|January 1, 2003
The complete receptor-binding domain of Clostridium difficile toxin A is required for endocytosisCornelia Frisch, Ralf Gerhard, Klaus Aktories, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 4, 2011
Therapeutic effects of Clostridium botulinum C3 exoenzymeIngo Just, Astrid Rohrbeck, Stefanie C Huelsenbeck, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 4, 2014
Binding of Clostridium botulinum C3 exoenzyme to intact cellsAstrid Rohrbeck, Leonie von Elsner, Sandra Hagemann, et al.
Toxins|February 5, 2015
Uptake of clostridium botulinum C3 exoenzyme into intact HT22 and J774A.1 cellsAstrid Rohrbeck, Leonie von Elsner, Sandra Hagemann, et al.
Journal of Molecular Signaling|September 14, 2018
Anti-proliferative Effect of C3 Exoenzyme in Fibroblasts is Mediated by c-Jun PhosphorylationLeonie von Elsner, Sandra Hagemann, Ingo Just, et al.
The International Journal of Biochemistry & Cell Biology|February 22, 2008
Clostridium difficile toxins: more than mere inhibitors of Rho proteinsHarald Genth, Stefanie C Dreger, Johannes Huelsenbeck, et al.
Infection and Immunity|September 22, 2006
Application of mutated Clostridium difficile toxin A for determination of glucosyltransferase-dependent effectsMatthias Teichert, Helma Tatge, Janett Schoentaube, et al.
The FEBS Journal|May 25, 2012
Distinct biological activities of C3 and ADP-ribosyltransferase-deficient C3-E174QAstrid Rohrbeck, Tanja Kolbe, Sandra Hagemann, et al.
Biochemical and Biophysical Research Communications|February 21, 2003
Activation of phospholipase D1 by ADP-ribosylated RhoAHarald Genth, Martina Schmidt, Ralf Gerhard, et al.
Cellular Microbiology|August 28, 2009
Serine-71 phosphorylation of Rac1/Cdc42 diminishes the pathogenic effect of Clostridium difficile toxin AJanett Schoentaube, Alexandra Olling, Helma Tatge, et al.
Biochemical and Biophysical Research Communications|January 1, 2003
The complete receptor-binding domain of Clostridium difficile toxin A is required for endocytosisCornelia Frisch, Ralf Gerhard, Klaus Aktories, et al.
Pageof 10